Photo from wikipedia
The rate of glucocorticoid (GC) use is significantly higher in systemic juvenile idiopathic arthritis (SJIA) than other juvenile idiopathic arthritis subtypes. There is no consensus on the duration and dosage… Click to show full abstract
The rate of glucocorticoid (GC) use is significantly higher in systemic juvenile idiopathic arthritis (SJIA) than other juvenile idiopathic arthritis subtypes. There is no consensus on the duration and dosage of GC treatment. We aimed to investigate the risk factors for a polyphasic / persistent disease course and the effect of dose and duration of GC treatment on SJIA prognosis.
Keywords:
prognosis;
idiopathic arthritis;
systemic juvenile;
juvenile idiopathic
Journal Title: Pediatrics International
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatrics International
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!